Cocrystal Pharma Inc. (NASDAQ: COCP)
$2.28
+0.0400 ( +1.79% ) 10.3K
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Market Data
Open
$2.28
Previous close
$2.24
Volume
10.3K
Market cap
$23.09M
Day range
$2.25 - $2.38
52 week range
$1.33 - $3.29
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 28, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 55 | May 13, 2024 |
def | Proxies and info statements | 1 | May 07, 2024 |
8-k | 8K-related | 15 | May 01, 2024 |
pre | Proxies and info statements | 1 | Apr 26, 2024 |
10-k/a | Quarterly Reports | 16 | Apr 17, 2024 |
10-k | Annual reports | 84 | Mar 28, 2024 |
8-k | 8K-related | 15 | Mar 28, 2024 |